Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.33% | -30.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.84% | -2.37% | |||
| Operating Income | 23.84% | 2.37% | |||
| Income Before Tax | 22.41% | -0.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.41% | -0.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.41% | -0.14% | |||
| EBIT | 23.84% | 2.37% | |||
| EBITDA | 24.86% | 2.47% | |||
| EPS Basic | 22.47% | -0.06% | |||
| Normalized Basic EPS | 22.47% | -0.06% | |||
| EPS Diluted | 22.47% | -0.06% | |||
| Normalized Diluted EPS | 22.47% | -0.06% | |||
| Average Basic Shares Outstanding | 0.08% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
